Literature DB >> 3123237

99mTc-HM-PAO for leukocyte labeling--experimental comparison with 111In oxine in dogs.

J G McAfee1, G Subramanian, G Gagne, R F Schneider, C Zapf-Longo.   

Abstract

99mTc-hexamethylpropylene amine oxime d,l diastereoisomer (HM-PAO), developed as a diffusible brain imaging agent, labels leukocyte suspensions in saline with an efficiency of 80% using 1-200 micrograms quantities. In dogs, the recovery and survival of reinjected cells in the bloodstream resemble those of 111In-oxine labeled cells at least for several hours. Images in control animals at 18 h show the spleen, liver, marrow, and bladder, minimal pulmonary activity and some gastrointestinal activity. Induced E. coli abscesses and joint inflammatory lesions in dogs are shown on 18 h images. This complex appears promising as an agent for abscess detection in humans. However, strict quality control of this agent is necessary, and it must be used immediately after the 99mTc complex is formed for labeling cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3123237     DOI: 10.1007/bf00252994

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  8 in total

1.  Cellular radiation doses of labeled neutrophils and platelets.

Authors:  D A Bassano; J G McAfee
Journal:  J Nucl Med       Date:  1979-03       Impact factor: 10.057

Review 2.  Technique of leukocyte harvesting and labeling: problems and perspectives.

Authors:  J G McAfee; G Subramanian; G Gagne
Journal:  Semin Nucl Med       Date:  1984-04       Impact factor: 4.446

Review 3.  The significance of chromosomal aberrations in indium-111-labeled lymphocytes.

Authors:  M L Thakur; J G McAfee
Journal:  J Nucl Med       Date:  1984-08       Impact factor: 10.057

4.  Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imaging.

Authors:  D P Nowotnik; L R Canning; S A Cumming; R C Harrison; B Higley; G Nechvatal; R D Pickett; I M Piper; V J Bayne; A M Forster
Journal:  Nucl Med Commun       Date:  1985-09       Impact factor: 1.690

5.  A comparative study of the brain uptake and early kinetics of 99mTc-dl HM-PAO and other PnAO derivatives in baboons.

Authors:  K Reichmann; H J Biersack; L Basso; A Hartmann; I T Matthews; R D Neirinckx; R D Pickett; C Winkler
Journal:  Nuklearmedizin       Date:  1986-08       Impact factor: 1.379

6.  Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation.

Authors:  A M Peters; H J Danpure; S Osman; R J Hawker; B L Henderson; H J Hodgson; J D Kelly; R D Neirinckx; J P Lavender
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

7.  Distribution of leukocytes labeled with In-111 oxine in dogs with acute inflammatory lesions.

Authors:  J G McAfee; G M Gagne; G Subramanian; Z D Grossman; F D Thomas; M L Roskopf; P Fernandes; B J Lyons
Journal:  J Nucl Med       Date:  1980-11       Impact factor: 10.057

8.  99mTc-propylene amine oxime (99mTc-PnAO); a potential brain radiopharmaceutical.

Authors:  W A Volkert; T J Hoffman; R M Seger; D E Troutner; R A Holmes
Journal:  Eur J Nucl Med       Date:  1984
  8 in total
  7 in total

1.  [Diagnosis of infection in surgery of the locomotor system with Tc-99m-HMPAO leukocyte scintigraphy].

Authors:  K H Winker; P Reuland; S Weller; U Feine
Journal:  Langenbecks Arch Chir       Date:  1989

2.  Radiochemical purity of D,L-hexamethylpropylene amine oxime and analysis of urine-excreted HMPAO decomposition species.

Authors:  V Ivancević; Z Kuster; Z Mastrović; D Ivancević
Journal:  Eur J Nucl Med       Date:  1990

3.  In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.

Authors:  M Ecclestone; A Proulx; J R Ballinger; B Gerson; R H Reid; K Y Gulenchyn
Journal:  Eur J Nucl Med       Date:  1990

4.  99mTc-labelling of leucocytes with 99mTc-DPO: a complex developed for myocardial imaging.

Authors:  G Endert; U Franke; P Kleinert
Journal:  Eur J Nucl Med       Date:  1989

5.  Evaluation of a new leukocyte labeling procedure with 99mTc-HMPAO.

Authors:  H Kelbaek; J Linde; S L Nielsen
Journal:  Eur J Nucl Med       Date:  1988

6.  Technetium-99m HMPAO labeled leukocytes in inflammation imaging.

Authors:  K Uno; K Yoshikawa; K Imazeki; S Minoshima; N Arimizu
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

7.  Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance.

Authors:  G Sciarretta; A Furno; M Mazzoni; C Basile; P Malaguti
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.